Prospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jul 21, 2021; 27(27): 4468-4480
Published online Jul 21, 2021. doi: 10.3748/wjg.v27.i27.4468
Table 1 Demographics of inflammatory bowel disease patients participating in inflammatory bowel disease-knowledge inventory device study
Variable
Categories of variable
Patients, n (%)
Patient’s genderFemale140 (52.0)
Male 129 (48.0)
Parent’s genderFemale232 (80.0)
Male 58 (20.0)
Place of residenceRural172 (57.9)
Urban125 (41.1)
Parent’s educationLower than secondary48 (16.2)
Secondary123 (41.6)
Higher than secondary125 (42.2)
Disease typeCD1196 (65.8)
UC2102 (34.2)
IBD family history50 (16.8)
J-elita membership64 (21.8)
Treatment modes
AminosalicylatesAll patients248 (83.2)
CD160 (81.6)
UC88 (86.3)
ImmunomodulatorsAll patients205 (68.8)
CD143 (73.0)
UC62 (60.8)
Biologic therapyAll patients99 (33.2)
CD81 (41.3)
UC18 (17.6)
Exclusive enteral nutritionAll patients98 (32.9)
CD85 (43.4)
UC13 (12.7)
Dietary counsellingAll patients90 (30.2)
CD67 (34.2)
UC23 (22.5)
Psychological supportAll patients53 (17.8)
CD34 (17.3)
UC19 (18.6)
Surgical treatmentAll patients30 (10.1)
CD27 (13.8)
UC3 (2.9)
Patient’s self-assessment of knowledgeGood120 (45.1)
Average125 (47.0)
Low21 (7.9)
Parent’s self-assessment of knowledgeGood152 (51.7)
Average122 (41.5)
Low20 (6.8)
Sources of parent’s information about disease
Physician241 (80.9)
Nurse66 (22.1)
Internet 197 (66.1)
Journals82 (27.5)
Books77 (25.8)